Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Sep 21;8:475–484. doi: 10.2147/CEOR.S114524

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Casado et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Cost-effectiveness acceptability curve (cost per QALY gained with GClb vs RClb).

Notes: The acceptability curve reflects, for a certain WTP value, the percentage of the 1,000 ICER values obtained in the probabilistic analysis, which would be lower than that value and would be regarded as cost-effective.

Abbreviations: GClb, obinutuzumab + chlorambucil; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year; RClb, rituximab + chlorambucil; WTP, willingness to pay.